Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 4;14(1):115.
doi: 10.3390/pharmaceutics14010115.

Enzymatic Synthesis and Antimicrobial Activity of Oligomer Analogues of Medicinal Biopolymers from Comfrey and Other Species of the Boraginaceae Family

Affiliations

Enzymatic Synthesis and Antimicrobial Activity of Oligomer Analogues of Medicinal Biopolymers from Comfrey and Other Species of the Boraginaceae Family

Maia Merlani et al. Pharmaceutics. .

Abstract

This study reports the first enzymatic synthesis leading to several oligomer analogues of poly[3-(3,4-dihydroxyphenyl)glyceric acid]. This biopolymer, extracted from plants of the Boraginaceae family has shown a wide spectrum of pharmacological properties, including antimicrobial activity. Enzymatic ring opening polymerization of 2-methoxycarbonyl-3-(3,4-dibenzyloxyphenyl)oxirane (MDBPO) using lipase from Candida rugosa leads to formation of poly[2-methoxycarbonyl-3-(3,4-dibenzyloxyphenyl)oxirane] (PMDBPO), with a degree of polymerization up to 5. Catalytic debenzylation of PMDBPO using H2 on Pd/C yields poly[2-methoxycarbonyl-3-(3,4-dihydroxyphenyl)oxirane] (PMDHPO) without loss in molecular mass. Antibacterial assessment of natural polyethers from different species of Boraginaceae family Symhytum asperum, S. caucasicum,S. grandiflorum, Anchusa italica, Cynoglossum officinale, and synthetic polymers, poly[2-methoxycarbonyl-3-(3,4-dimethoxyphenyl)oxirane (PMDMPO) and PMDHPO, reveals that only the synthetic analogue produced in this study (PMDHPO) exhibits a promising antimicrobial activity against pathogenic strains S.aureus ATCC 25923 and E.coli ATCC 25922 the minimum inhibitory concentration (MIC) being 100 µg/mL.

Keywords: Boraginaceae family; antimicrobial activity; enzymatic polymerization; lipase; poly[3-(3,4-dihydroxyphenyl)glyceric acid].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
(a) Comfrey (S. officinale) plant leaves and flower. This file is licensed under the Creative Commons Attribution-Share Alike 3.0 Unported. credit to: User: Aiwok/Wikimedia Commons/CC-BY-SA-3.0 [6] (b) A. Italica (roots). Source: A voucher specimen TBPH-224 of A.italica is deposited in the Herbarium of the Institute of Pharmacochemistry, Tbilisi State Medical University (TSMU), Tbilisi, Georgia. (c) S. caucasicum. Source: A voucher specimen TBPH-20996 of S. caucasicum is deposited in the Herbarium of the Institute of Pharmacochemistry, TSMU, Tbilisi, Georgia.
Figure 2
Figure 2
Poly[3-(3,4-dihydroxyphenyl)glyceric acid] (PDHPGA) (1) and poly[2-methoxycarbonyl-3-(3,4-dihydroxyphenyl)oxirane] (PMDHPO) (2).
Figure 3
Figure 3
2-methoxycarbonyl-3-(3,4-dimethoxyphenyl)oxirane (MDMPO) (3), 2-methoxycarbonyl-3-(3,4-dibenzyloxyphenyl)-oxirane (MDBPO) (4), 2-benzyloxycarbonyl-3-(3,4-dibenzyloxyphenyl)oxirane (BDBPO) (5), 2-t-butyloxycarbonyl-3-(3,4-dibenzyloxyphenyl)oxirane (TBDBPO) (6).
Scheme 1
Scheme 1
Enzymatic polymerization of MDBPO and modification of the polymer: (a) C. rugosa lipase, toluene, 80 °C, 7 days (b) Pd/C, H2, THF/EtOH.
Figure 4
Figure 4
SEC traces of MDBPO monomer (1, green trace) and polymer PMDBPO (2, black trace). X—internal standard. See experimental for analysis conditions.
Figure 5
Figure 5
MALDI-TOF mass spectrum of PMDBPO. See experimental for analysis conditions.

References

    1. Salehi B., Sharopov F., Tumer T.B., Ozleyen A., Rodríguez-Pérez C., Ezzat S.M., Azzini E., Hosseinabadi T., Butnariu M., Sarac I., et al. Symphytum species: A comprehensive review on chemical composition, food applications and phytopharmacology. Molecules. 2019;24:2272. doi: 10.3390/molecules24122272. - DOI - PMC - PubMed
    1. Araujo L.U., Reis P.G., Barbos L.C.O., Saude-Guimarгes D.A., Grabe-Guimarгes A., Mosqueira V.C.F., Carneiro C.M., Silva-Barcellos N.M. In vivo wound healing effects of Symphytum officinale L. leaves extract in different topical formulations. Pharmazie. 2012;67:355–360. doi: 10.1691/ph.2012.1563. - DOI - PubMed
    1. Staiger C. Comfrey: A clinical overview. Phytother. Res. 2012;26:1441–1448. doi: 10.1002/ptr.4612. - DOI - PMC - PubMed
    1. Al-Snafi A.E. The pharmacology of Anchusa italica and Anchusa strigosa. Int. J. Pharm. Pharm. Sci. 2014;6:7–10.
    1. Baghiani A., Boussoualim N., Trabsa H., Aouachria S., Arrar L. In vivo free radical scavenging, antihemolytic activity and antibacterial effects of Anchusa azurea extracts. Int. J. Med. Med. Sci. 2013;46:1113–1118.

LinkOut - more resources